TheracosBio
Brian Connelly currently serves as Chief Executive Officer at TheracosBio, a position held since July 2023. With a wealth of experience in the biotech and legal fields, Brian has been Of Counsel at Faber Daeufer & Itrato PC since December 2007 and Principal at Kingsmark Consulting LLC since February 2022, where consultation is provided to biotech startups on quality management systems and operational matters. Previously, Brian co-founded and held the role of COO at IncreVet, Inc. from February 2018 to February 2022, and worked as Senior Manager of Business Development and Associate General Counsel at IDEXX Laboratories from September 2003 to November 2007. Brian earned a Juris Doctor from The George Washington University Law School (1996) and a Bachelor of Arts from Boston College (1993).
This person is not in any teams
TheracosBio
TheracosBio is a pharmaceutical company located in Marlborough, Massachusetts. TheracosBio discovers, develops and commercializes medicines for important diseases. TheracosBio believes that affordable medications for prevalent conditions may lead to more rapid advances in public health. TheracosBio has gained FDA approval of its proprietary medicine Brenzavvy™ (bexagliflozin). Press release: https://bit.ly/3HtSZ6y